Article Details
Retrieved on: 2024-07-11 11:44:12
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the exponential growth of the antibody-drug conjugates (ADCs) market, driven by rising cancer incidences. The report highlights major players, including Seagen and ImmunoGen, underscoring the relevance of biotechnology and immunology in biopharma advancements.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here